<DOC>
	<DOC>NCT01882816</DOC>
	<brief_summary>The purpose of this Phase 2 study is to find out what effect, good and/or bad, external beam radiation therapy, has on the patient and their thyroid cancer where surgery is not an option or where despite surgery, the disease is still present.</brief_summary>
	<brief_title>Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>Pathologically confirmed diagnosis of nonanaplastic nonmedullary thyroid cancer that is either grossly recurrent after surgery or unresectable with or without metastatic disease. Age ≥18 years Karnofsky performance status ≥70% Men and women of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 3 months after treatment. Patients must have ability to understand and the willingness to sign a written informed consent document. Women who are pregnant or lactating Inability to comply with study and/or followup procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>non-anaplastic</keyword>
	<keyword>non-medullary</keyword>
	<keyword>radiation</keyword>
	<keyword>IMRT</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>13-070</keyword>
</DOC>